EyePoint Pharmaceuticals (EYPT) Reports Q3 Loss, Lags Revenue Estimates

EyePoint Pharmaceuticals (EYPT) came out with a quarterly loss of $0.54 per share versus the Zacks Consensus Estimate of a loss of$ 0.48. This compares to loss of $0.33 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -12.50%. A quarter ago, it was expected that this drug delivery technology company would post a loss of$ 0.55 per share when it actually produced a loss of $0.58, delivering a surprise of -5.45%.Over the last four ...